{"ticker": {"uuid": "fe21a17c-6fdf-42c3-8e76-19bd3a234024", "symbol": "DHR", "name": "Danaher Corporation", "exchange": "MEX", "country": "MX", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination", "summary": "Nature Communications study finds UNCOVERseq\u2122 delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions relevant to emerging regulatory expectations for genome-editing safety studies CORALVILLE, Iowa, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/integrated-dna-technologies-scientists-set-125300711.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T12:53:00+00:00", "published_display": "11 Aug 2026 12:53", "sentiment": "positive", "sentiment_pct": 60, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.438, "duplicate_count": 1, "topics": ["Bioinformatics", "Crispr", "Genome Editing", "Regulation", "Therapeutic Development"]}, {"title": "Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?", "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher's (NYSE:DHR) recovery remains more uneven. Which stock looks better positioned for the next phase of the life sciences rebound?Top Long-Term Biotechnology Stocks", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-tmo-vs-danaher-000131616.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T00:01:31+00:00", "published_display": "10 Aug 2026 00:01", "sentiment": "positive", "sentiment_pct": 87, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.35, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Fourth Quarter", "Guidance", "Healthcare", "Institutional Investors"]}], "by_tier": {"direct": [{"title": "Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination", "summary": "Nature Communications study finds UNCOVERseq\u2122 delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions relevant to emerging regulatory expectations for genome-editing safety studies CORALVILLE, Iowa, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/integrated-dna-technologies-scientists-set-125300711.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T12:53:00+00:00", "published_display": "11 Aug 2026 12:53", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 60, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.438, "duplicate_count": 1, "topics": ["Bioinformatics", "Crispr", "Genome Editing", "Regulation", "Therapeutic Development"]}, {"title": "Thermo Fisher (TMO) vs Danaher (DHR): Which Life Sciences Stock Looks Better Positioned?", "summary": "Thermo Fisher Scientific Inc. (NYSE:TMO) and Danaher Corporation (NYSE:DHR) are two of the world's largest life sciences tools companies, making them natural competitors for investors looking to capitalize on a recovery in pharmaceutical and biotechnology research spending. Both companies delivered better-than-expected second-quarter results, but while Thermo Fisher (NYSE:TMO) raised guidance on broad-based demand improvement, Danaher's (NYSE:DHR) recovery remains more uneven. Which stock looks better positioned for the next phase of the life sciences rebound?Top Long-Term Biotechnology Stocks", "url": "https://finance.yahoo.com/healthcare/articles/thermo-fisher-tmo-vs-danaher-000131616.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T00:01:31+00:00", "published_display": "10 Aug 2026 00:01", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 87, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.35, "duplicate_count": 1, "topics": ["Biotech", "Earnings", "Fourth Quarter", "Guidance", "Healthcare", "Institutional Investors"]}], "industry": [], "sector": []}, "total_fetched": 2, "total_unique": 2, "total_relevant": 2, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 2}, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 350, "call_budget": 500, "budget_used_pct": 70.0, "requests_made": 70, "last_success_at": "2026-08-13T13:15:18.358444+00:00", "newest_seen_at": "2026-08-13T13:11:03+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 2540, "unmapped_mentions": 1958}, "status": "healthy", "durable_evidence_used": true, "durable_collected_at": "2026-08-12T21:38:36.522751+00:00", "durable_newest_article_at": "2026-08-11T12:53:00+00:00", "durable_story_count": 1}, "sentiment_summary": {"positive": 2, "negative": 0, "neutral": 0, "score": 60, "raw_score": 72, "total": 2, "evidence_count": 2, "effective_articles": 1.98, "direct_story_count": 2, "industry_story_count": 0, "sector_story_count": 0, "story_count": 2, "source_count": 1, "source_concentration": 1.0, "direct_share": 100, "dispersion": 13, "confidence": 51, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-11T12:53:00+00:00", "label": "Constructive news tone", "tone": "positive"}, "classifier": {"primary_event": "regulatory", "primary_label": "Regulatory and legal", "confidence": 58, "events": [{"event": "regulatory", "label": "Regulatory and legal", "weight": 0.6, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.6, "count": 1}], "positive_events": 2, "negative_events": 0, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 2}, "raw_articles": 2, "unique_stories": 2, "duplicates_removed": 0, "relevant_stories": 2, "current_evidence": 2, "direct_evidence": 2, "eodhd_articles": 2, "eodhd": {"configured": true, "status": "healthy", "calls_used": 350, "call_budget": 500, "budget_used_pct": 70.0, "requests_made": 70, "last_success_at": "2026-08-13T13:15:18.358444+00:00", "newest_seen_at": "2026-08-13T13:11:03+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 2540, "unmapped_mentions": 1958}, "status": "healthy", "durable_evidence_used": true, "durable_collected_at": "2026-08-12T21:38:36.522751+00:00", "durable_newest_article_at": "2026-08-11T12:53:00+00:00", "durable_story_count": 1}}, "market_context": {"has_market_context": true, "latest_close": 3490.0, "latest_week": "2026-08-07", "one_week_move": 2.6, "four_week_move": -0.2, "twelve_week_move": 24.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.029691, "market_dynamics_buy_signal": false, "relative_strength": -6.074122, "fair_value_gap": -14.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.0479, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.6% over one week, -0.2% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "News confirmed by price", "tone": "positive", "classification": "confirmed_positive", "summary": "Constructive news tone is being confirmed by positive weekly price action.", "confidence": 60, "badges": ["Sentiment-trend disagreement"], "opportunities": [], "risks": ["Positive news is arriving while the Sharemaestro trend signal is inactive."], "event_label": "Regulatory and legal", "sentiment_word": "constructive"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Regulatory and legal", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "60/100", "tone": "positive", "text": "Constructive news tone"}, {"label": "Evidence confidence", "value": "51/100", "tone": "neutral", "text": "1.98 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "News confirmed by price", "tone": "positive", "text": "Constructive news tone is being confirmed by positive weekly price action."}, {"label": "Primary event", "value": "Regulatory and legal", "tone": "positive", "text": "58/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "13/100", "tone": "positive", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.6% over one week, -0.2% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination"}], "updated_at": "2026-08-12T21:38:36.522751+00:00", "detail_intelligence": {"headline": "News confirmed by price", "summary": "Constructive news tone is drawn from 2 fresh independent stories, including 2 company-specific items across 1 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 60, "display": "60", "tone": "positive", "note": "Constructive news tone"}, {"label": "Evidence confidence", "value": 51, "display": "51", "tone": "neutral", "note": "building confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "2 direct stories"}, {"label": "Evidence agreement", "value": 87, "display": "87", "tone": "positive", "note": "13/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 25, "note": "1.98 effective stories"}, {"label": "Source breadth", "value": 20, "note": "1 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 65, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 87, "note": "cross-story consistency"}, {"label": "Source independence", "value": 0, "note": "lower publisher concentration"}], "freshness": 65, "source_independence": 0, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 0, "score": null, "tone": "neutral", "x": 683.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 1, "score": 87, "tone": "positive", "x": 820.6, "y": 67.7, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 1, "score": 60, "tone": "positive", "x": 866.4, "y": 116.8, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-12", "label": "12 Aug", "count": 0, "score": null, "tone": "neutral", "x": 912.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "820.6,67.7 866.4,116.8", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Deteriorating", "tone": "negative", "recent_score": 60, "prior_score": 87, "delta": -27, "recent_count": 1, "prior_count": 1, "volume_delta": 0}, "freshness_buckets": [{"label": "Last 24 hours", "count": 0, "share": 0}, {"label": "1 to 3 days", "count": 1, "share": 50}, {"label": "4 to 7 days", "count": 1, "share": 50}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 2, "share": 100, "score": 72, "tone": "positive"}], "event_profile": [{"label": "Guidance", "count": 1, "share": 50, "score": 87, "tone": "positive"}, {"label": "Regulatory and legal", "count": 1, "share": 50, "score": 60, "tone": "positive"}], "topics": [{"label": "Therapeutic Development", "count": 1, "share": 50}, {"label": "Regulation", "count": 1, "share": 50}, {"label": "Institutional Investors", "count": 1, "share": 50}, {"label": "Healthcare", "count": 1, "share": 50}, {"label": "Guidance", "count": 1, "share": 50}, {"label": "Genome Editing", "count": 1, "share": 50}, {"label": "Fourth Quarter", "count": 1, "share": 50}, {"label": "Earnings", "count": 1, "share": 50}, {"label": "Crispr", "count": 1, "share": 50}, {"label": "Biotech", "count": 1, "share": 50}], "supporting": [{"label": "Direct evidence", "text": "2 current stories are mapped specifically to DHR."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 87/100, indicating a comparatively coherent tape."}, {"label": "Price response", "text": "Constructive news tone is being confirmed by positive weekly price action."}], "tempering": [{"label": "Source breadth", "text": "Only 1 publisher currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination", "summary": "Nature Communications study finds UNCOVERseq\u2122 delivered the strongest combined sensitivity and precision among evaluated CRISPR off-target nomination methods Findings provide a more rigorous framework for prioritizing potential off-target sites for confirmation and safety assessment in CRISPR-based therapeutic development, supporting more confident progress from promising science toward responsible therapeutic impact Study defines sequencing, replication and process-control conditions relevant to emerging regulatory expectations for genome-editing safety studies CORALVILLE, Iowa, August 11, 20", "url": "https://finance.yahoo.com/healthcare/articles/integrated-dna-technologies-scientists-set-125300711.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T12:53:00+00:00", "published_display": "11 Aug 2026 12:53", "sentiment": "positive", "sentiment_pct": 60, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.45, "duplicate_count": 1, "topics": ["Bioinformatics", "Crispr", "Genome Editing", "Regulation", "Therapeutic Development"]}, "article_count": 2, "updated_at": "2026-08-12T21:38:36.522751+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 55.8, "label": "13 Feb 2026", "close": 3629.57, "index": 100.0}, {"x": 77.4, "y": 61.1, "label": "20 Feb 2026", "close": 3599.57, "index": 99.2}, {"x": 112.9, "y": 62.0, "label": "27 Feb 2026", "close": 3594.57, "index": 99.0}, {"x": 148.3, "y": 78.2, "label": "06 Mar 2026", "close": 3503.58, "index": 96.5}, {"x": 183.8, "y": 107.8, "label": "13 Mar 2026", "close": 3337.29, "index": 91.9}, {"x": 219.2, "y": 98.5, "label": "20 Mar 2026", "close": 3389.6, "index": 93.4}, {"x": 254.7, "y": 115.9, "label": "27 Mar 2026", "close": 3291.65, "index": 90.7}, {"x": 290.1, "y": 102.6, "label": "03 Apr 2026", "close": 3366.03, "index": 92.7}, {"x": 325.6, "y": 114.6, "label": "10 Apr 2026", "close": 3298.8, "index": 90.9}, {"x": 361.0, "y": 91.3, "label": "17 Apr 2026", "close": 3430.0, "index": 94.5}, {"x": 396.4, "y": 148.2, "label": "24 Apr 2026", "close": 3109.59, "index": 85.7}, {"x": 431.9, "y": 144.3, "label": "01 May 2026", "close": 3131.59, "index": 86.3}, {"x": 467.3, "y": 178.4, "label": "08 May 2026", "close": 2939.62, "index": 81.0}, {"x": 502.8, "y": 204.2, "label": "15 May 2026", "close": 2794.64, "index": 77.0}, {"x": 538.2, "y": 168.5, "label": "22 May 2026", "close": 2995.61, "index": 82.5}, {"x": 573.7, "y": 136.1, "label": "29 May 2026", "close": 3177.59, "index": 87.5}, {"x": 609.1, "y": 127.9, "label": "05 Jun 2026", "close": 3223.65, "index": 88.8}, {"x": 644.6, "y": 152.2, "label": "12 Jun 2026", "close": 3086.93, "index": 85.0}, {"x": 680.0, "y": 156.7, "label": "19 Jun 2026", "close": 3062.01, "index": 84.4}, {"x": 715.4, "y": 101.0, "label": "26 Jun 2026", "close": 3375.0, "index": 93.0}, {"x": 750.9, "y": 97.0, "label": "03 Jul 2026", "close": 3398.0, "index": 93.6}, {"x": 786.3, "y": 79.3, "label": "10 Jul 2026", "close": 3497.39, "index": 96.4}, {"x": 821.8, "y": 69.9, "label": "17 Jul 2026", "close": 3550.0, "index": 97.8}, {"x": 857.2, "y": 104.6, "label": "24 Jul 2026", "close": 3355.0, "index": 92.4}, {"x": 892.7, "y": 96.3, "label": "31 Jul 2026", "close": 3402.0, "index": 93.7}, {"x": 928.1, "y": 80.6, "label": "07 Aug 2026", "close": 3490.0, "index": 96.2}], "sentiment_points": [{"x": 704.7, "y": 119.0, "label": "23 Jun 2026", "score": 56}, {"x": 705.6, "y": 124.5, "label": "24 Jun 2026", "score": 53}, {"x": 710.5, "y": 120.8, "label": "25 Jun 2026", "score": 55}, {"x": 710.6, "y": 122.6, "label": "25 Jun 2026", "score": 54}, {"x": 711.1, "y": 122.6, "label": "25 Jun 2026", "score": 54}, {"x": 733.3, "y": 124.5, "label": "29 Jun 2026", "score": 53}, {"x": 733.4, "y": 126.3, "label": "29 Jun 2026", "score": 52}, {"x": 738.7, "y": 122.6, "label": "30 Jun 2026", "score": 54}, {"x": 738.8, "y": 122.6, "label": "30 Jun 2026", "score": 54}, {"x": 743.5, "y": 120.8, "label": "01 Jul 2026", "score": 55}, {"x": 754.1, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 754.8, "y": 120.8, "label": "03 Jul 2026", "score": 55}, {"x": 755.4, "y": 122.6, "label": "03 Jul 2026", "score": 54}, {"x": 767.6, "y": 122.6, "label": "06 Jul 2026", "score": 54}, {"x": 768.3, "y": 122.6, "label": "06 Jul 2026", "score": 54}, {"x": 773.9, "y": 122.6, "label": "07 Jul 2026", "score": 54}, {"x": 777.4, "y": 124.5, "label": "08 Jul 2026", "score": 53}, {"x": 779.0, "y": 124.5, "label": "08 Jul 2026", "score": 53}, {"x": 784.0, "y": 117.1, "label": "09 Jul 2026", "score": 57}, {"x": 785.5, "y": 117.1, "label": "09 Jul 2026", "score": 57}, {"x": 787.7, "y": 119.0, "label": "10 Jul 2026", "score": 56}, {"x": 789.2, "y": 119.0, "label": "10 Jul 2026", "score": 56}, {"x": 804.2, "y": 124.5, "label": "13 Jul 2026", "score": 53}, {"x": 809.7, "y": 124.5, "label": "14 Jul 2026", "score": 53}, {"x": 811.1, "y": 122.6, "label": "14 Jul 2026", "score": 54}, {"x": 812.1, "y": 124.5, "label": "15 Jul 2026", "score": 53}, {"x": 813.6, "y": 124.5, "label": "15 Jul 2026", "score": 53}, {"x": 820.2, "y": 124.5, "label": "16 Jul 2026", "score": 53}, {"x": 824.4, "y": 126.3, "label": "17 Jul 2026", "score": 52}, {"x": 840.5, "y": 128.2, "label": "20 Jul 2026", "score": 51}, {"x": 844.7, "y": 117.1, "label": "21 Jul 2026", "score": 57}, {"x": 854.2, "y": 126.3, "label": "23 Jul 2026", "score": 52}, {"x": 858.2, "y": 120.8, "label": "24 Jul 2026", "score": 55}, {"x": 859.2, "y": 122.6, "label": "24 Jul 2026", "score": 54}, {"x": 873.9, "y": 122.6, "label": "27 Jul 2026", "score": 54}, {"x": 884.9, "y": 126.3, "label": "29 Jul 2026", "score": 52}, {"x": 885.4, "y": 126.3, "label": "29 Jul 2026", "score": 52}, {"x": 888.7, "y": 126.3, "label": "30 Jul 2026", "score": 52}, {"x": 890.5, "y": 126.3, "label": "30 Jul 2026", "score": 52}, {"x": 891.6, "y": 126.3, "label": "30 Jul 2026", "score": 52}, {"x": 892.0, "y": 124.5, "label": "30 Jul 2026", "score": 53}, {"x": 894.0, "y": 122.6, "label": "31 Jul 2026", "score": 54}, {"x": 895.7, "y": 124.5, "label": "31 Jul 2026", "score": 53}, {"x": 895.9, "y": 124.5, "label": "31 Jul 2026", "score": 53}, {"x": 896.2, "y": 120.8, "label": "31 Jul 2026", "score": 55}, {"x": 896.9, "y": 124.5, "label": "31 Jul 2026", "score": 53}, {"x": 897.3, "y": 124.5, "label": "31 Jul 2026", "score": 53}, {"x": 909.4, "y": 122.6, "label": "03 Aug 2026", "score": 54}, {"x": 920.6, "y": 124.5, "label": "05 Aug 2026", "score": 53}, {"x": 933.2, "y": 128.2, "label": "08 Aug 2026", "score": 51}, {"x": 948.9, "y": 107.9, "label": "11 Aug 2026", "score": 62}, {"x": 958.0, "y": 111.6, "label": "12 Aug 2026", "score": 60}], "price_path": "42.0,55.8 77.4,61.1 112.9,62.0 148.3,78.2 183.8,107.8 219.2,98.5 254.7,115.9 290.1,102.6 325.6,114.6 361.0,91.3 396.4,148.2 431.9,144.3 467.3,178.4 502.8,204.2 538.2,168.5 573.7,136.1 609.1,127.9 644.6,152.2 680.0,156.7 715.4,101.0 750.9,97.0 786.3,79.3 821.8,69.9 857.2,104.6 892.7,96.3 928.1,80.6", "sentiment_path": "704.7,119.0 705.6,124.5 710.5,120.8 710.6,122.6 711.1,122.6 733.3,124.5 733.4,126.3 738.7,122.6 738.8,122.6 743.5,120.8 754.1,122.6 754.8,120.8 755.4,122.6 767.6,122.6 768.3,122.6 773.9,122.6 777.4,124.5 779.0,124.5 784.0,117.1 785.5,117.1 787.7,119.0 789.2,119.0 804.2,124.5 809.7,124.5 811.1,122.6 812.1,124.5 813.6,124.5 820.2,124.5 824.4,126.3 840.5,128.2 844.7,117.1 854.2,126.3 858.2,120.8 859.2,122.6 873.9,122.6 884.9,126.3 885.4,126.3 888.7,126.3 890.5,126.3 891.6,126.3 892.0,124.5 894.0,122.6 895.7,124.5 895.9,124.5 896.2,120.8 896.9,124.5 897.3,124.5 909.4,122.6 920.6,124.5 933.2,128.2 948.9,107.9 958.0,111.6", "price_change": -3.8, "sentiment_change": 4, "latest_close": 3490.0, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}